Literature DB >> 10383391

Hyperphosphorylation of the retinoid X receptor alpha by activated c-Jun NH2-terminal kinases.

S Adam-Stitah1, L Penna, P Chambon, C Rochette-Egly.   

Abstract

The nuclear receptor mouse retinoid X receptor alpha (mRXRalpha) was shown to be constitutively phosphorylated in its NH2-terminal A/B region, which contains potential phosphorylation sites for proline-directed Ser/Thr kinases. Mutants for each putative site were generated and overexpressed in transfected COS-1 cells. Constitutively phosphorylated residues identified by tryptic phosphopeptide mapping included serine 22 located in the A1 region that is specific to the RXRalpha1 isoform. Overexpression and UV activation of the stress-activated kinases, c-Jun NH2-terminal kinases 1 and 2 (JNK1 and JNK2), hyperphosphorylated RXRalpha, resulting in a marked decrease in its electrophoretic mobility. This inducible hyperphosphorylation involved three residues (serines 61 and 75 and threonine 87) in the B region of RXRalpha and one residue (serine 265) in the ligand binding domain (E region). Binding assays performed in vitro with purified recombinant proteins demonstrated that JNKs did not interact with RXRalpha but bound to its heterodimeric partners, retinoic acid receptors alpha and gamma (RARalpha and RARgamma). Hyperphosphorylation by JNKs did not affect the transactivation properties of either RXRalpha homodimers or RXRalpha/RARalpha heterodimers in transfected cultured cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10383391     DOI: 10.1074/jbc.274.27.18932

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Ligand-dependent degradation of retinoid X receptors does not require transcriptional activity or coactivator interactions.

Authors:  D L Osburn; G Shao; H M Seidel; I G Schulman
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

Review 2.  Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases.

Authors:  Marie A Bogoyevitch; Bostjan Kobe
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

Review 3.  Cell signaling and nuclear receptors: new opportunities for molecular pharmaceuticals in liver disease.

Authors:  Jeff L Staudinger; Kristin Lichti
Journal:  Mol Pharm       Date:  2007-12-27       Impact factor: 4.939

Review 4.  Nuclear receptors and inflammatory diseases.

Authors:  Kun Wang; Yu-Jui Yvonne Wan
Journal:  Exp Biol Med (Maywood)       Date:  2008-03-28

5.  High glucose-induced repression of RAR/RXR in cardiomyocytes is mediated through oxidative stress/JNK signaling.

Authors:  Amar B Singh; Rakeshwar S Guleria; Irina T Nizamutdinova; Kenneth M Baker; Jing Pan
Journal:  J Cell Physiol       Date:  2012-06       Impact factor: 6.384

6.  AEG-1 regulates retinoid X receptor and inhibits retinoid signaling.

Authors:  Jyoti Srivastava; Chadia L Robertson; Devaraja Rajasekaran; Rachel Gredler; Ayesha Siddiq; Luni Emdad; Nitai D Mukhopadhyay; Shobha Ghosh; Phillip B Hylemon; Gregorio Gil; Khalid Shah; Deepak Bhere; Mark A Subler; Jolene J Windle; Paul B Fisher; Devanand Sarkar
Journal:  Cancer Res       Date:  2014-08-15       Impact factor: 12.701

7.  Constitutive activation of the mitogen-activated protein kinase pathway impairs vitamin D signaling in human prostate epithelial cells.

Authors:  Zhentao Zhang; Pavlo Kovalenko; Min Cui; Marsha Desmet; Steven K Clinton; James C Fleet
Journal:  J Cell Physiol       Date:  2010-08       Impact factor: 6.384

8.  Cocaine induces nuclear export and degradation of neuronal retinoid X receptor-γ via a TNF-α/JNK- mediated mechanism.

Authors:  Jane Kovalevich; William Yen; Ahmet Ozdemir; Dianne Langford
Journal:  J Neuroimmune Pharmacol       Date:  2015-01-14       Impact factor: 4.147

Review 9.  Targeting truncated RXRα for cancer therapy.

Authors:  Xiaokun Zhang; Hu Zhou; Ying Su
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2015-10-21       Impact factor: 3.848

10.  Redundant roles for cJun-N-terminal kinase 1 and 2 in interleukin-1beta-mediated reduction and modification of murine hepatic nuclear retinoid X receptor alpha.

Authors:  Astrid Kosters; Damara D White; Hongdan Sun; Sundararajah Thevananther; Saul J Karpen
Journal:  J Hepatol       Date:  2009-08-20       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.